HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roger S Rittmaster Selected Research

Dutasteride (Avodart)

12/2013Comparison of Classic and International Society of Urological Pathology 2005 Modified Gleason grading using needle biopsies from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial.
4/2013Genome-wide association study identifies genetic determinants of urine PCA3 levels in men.
1/2013Genome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA.
12/2012Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial.
12/2012Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men.
4/2012Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study.
3/2012Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial.
1/2012A comparison of Bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk.
10/2011Dutasteride reduces prostatitis symptoms compared with placebo in men enrolled in the REDUCE study.
9/2011Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roger S Rittmaster Research Topics

Disease

28Prostatic Neoplasms (Prostate Cancer)
12/2013 - 01/2005
10Neoplasms (Cancer)
12/2013 - 01/2005
6Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
09/2011 - 04/2006
2Pain (Aches)
10/2011 - 09/2007
2Prostatitis
10/2011 - 09/2007
2Lower Urinary Tract Symptoms
09/2011 - 02/2011
2Urinary Retention
09/2011 - 04/2010
1Hypertension (High Blood Pressure)
04/2012
1Weight Loss (Weight Reduction)
04/2012
1Hypercholesterolemia
04/2012
1Glucose Intolerance
07/2011
1Erectile Dysfunction
07/2011
1Heart Failure
04/2010
1Pelvic Pain
09/2007
1Inflammation (Inflammations)
09/2007
1Alopecia (Baldness)
12/2006
1Hypophosphatemia
11/2006
1Familial Hypophosphatemia (Phosphate Diabetes)
11/2006

Drug/Important Bio-Agent (IBA)

28Dutasteride (Avodart)FDA Link
12/2013 - 01/2005
7Prostate-Specific Antigen (Semenogelase)IBA
01/2013 - 04/2008
7Finasteride (Propecia)FDA LinkGeneric
08/2011 - 12/2006
4Dihydrotestosterone (Androstanolone)IBA
12/2012 - 04/2006
4Testosterone (Sustanon)FDA Link
07/2011 - 04/2006
2AndrogensIBA
12/2012 - 04/2006
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2012 - 05/2009
2IsoenzymesIBA
04/2008 - 02/2008
1Messenger RNA (mRNA)IBA
04/2013
1Biomarkers (Surrogate Marker)IBA
04/2013
1DNA (Deoxyribonucleic Acid)IBA
12/2012
1CholesterolIBA
04/2012
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
04/2012
1Estrogens (Estrogen)FDA Link
06/2011
1Tamsulosin (Flomax)FDA LinkGeneric
02/2011
1Indicators and Reagents (Reagents)IBA
01/2011
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2009
1Selective Estrogen Receptor Modulators (SERM)IBA
05/2009
1Cholestenone 5 alpha-Reductase (5 alpha-Reductase)IBA
05/2009
1hydroxide ionIBA
11/2006
1Phosphates (Orthophosphate)IBA
11/2006
1Proteins (Proteins, Gene)FDA Link
11/2006

Therapy/Procedure

4Chemoprevention
08/2011 - 09/2007
3Therapeutics
03/2012 - 04/2010
1Prostatectomy (Retropubic Prostatectomy)
01/2005